publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
e
r
c
n
p
h
r
c
c
n
wwwjaphaorg
r
ap
r
japha
special
featur
abstract
object
provid
gener
descript
role
contribut
three
pharmacist
regulatori
j
u
r
n
l
f
h
e
ne
hallmark
pharmaci
profess
opportun
contribut
health
promot
diseas
prevent
variou
way
tradit
mean
describ
divers
effect
pharmacist
public
health
current
work
share
experi
three
pharmacist
within
regulatori
affair
program
ra
center
diseas
control
prevent
cdc
ra
hold
uniqu
respons
vari
held
regulatori
affair
program
tradit
within
pharmaceut
compani
mission
ra
support
critic
task
ensur
avail
use
medic
countermeasur
essenti
cdc
prepared
emerg
respons
program
ra
execut
mission
ensur
regulatori
complianc
regard
critic
medic
countermeasur
potenti
threat
natur
chemic
biolog
radiolog
nuclear
cbrn
event
enabl
rapid
effect
respons
emerg
event
requir
appropri
use
medic
countermeasur
mani
avail
cdc
ra
respons
ensur
appropri
regulatori
mechan
investig
new
drug
ind
applic
emerg
use
author
eua
request
investig
devic
exempt
ide
requir
deploy
use
medic
countermeasur
place
ra
also
provid
regulatori
expertis
cdc
subject
matter
expert
princip
investig
regard
use
medic
product
eg
drug
biolog
devic
nonresearch
research
purpos
follow
attack
septemb
anthrax
event
us
depart
health
human
servic
hh
increas
effort
procur
develop
medic
countermeasur
cbrn
threat
consequ
cdc
role
lead
agenc
respons
prepared
respons
public
health
emerg
involv
bioterror
categori
agent
eg
smallpox
botul
anthrax
plagu
viral
hemorrhag
fever
tularemia
emerg
public
health
threat
eg
avian
influenza
pandem
influenza
monkeypox
sever
acut
respiratori
syndrom
also
expand
one
notabl
expans
manag
medic
countermeasur
cbrn
emerg
threat
medic
countermeasur
stockpil
cdc
strateg
nation
stockpil
consist
drug
biolog
devic
medic
countermeasur
use
treatment
mitig
prevent
seriou
lifethreaten
conditionsdiseas
result
cbrn
potenti
public
health
threat
mani
medic
countermeasur
consid
investig
product
ie
unapprov
product
unapprov
use
approv
product
food
drug
administr
fda
moreov
addit
medic
countermeasur
cbrn
public
health
threat
develop
consid
procur
investig
anticip
fda
approv
prior
stockpil
therefor
investig
medic
countermeasur
requir
fdaregul
mechan
ind
applic
ide
applic
eua
request
fdaregul
applic
receipt
stockpil
deploy
use
respons
potenti
actual
public
health
event
result
expans
becam
essenti
cdc
prepar
submit
time
manner
highqual
ind
ide
document
fda
ra
entiti
within
cdc
respons
central
ensur
cdc
consist
submiss
commun
fda
ra
fulfil
respons
ensur
appropri
regulatori
mechan
stockpil
deploy
use
investig
medic
countermeasur
addit
ra
ensur
complianc
law
regul
applic
part
code
feder
regul
titl
enforc
fda
deliv
specif
activ
limit
coordin
draft
review
submit
maintain
applic
regul
fda
eg
ind
ide
eua
k
activ
ensur
deploy
use
strateg
nation
stockpil
investig
medic
countermeasur
medic
countermeasur
avail
cdc
eg
therapeut
rare
diseas
unit
state
parasit
tropic
diseas
adher
fda
regul
first
member
ra
pharmacist
debra
yeskey
pharmd
current
ra
staff
consist
nine
individu
variou
background
includ
regulatori
pharmaci
immunolog
microbiolog
public
health
among
other
ra
staff
function
team
collabor
develop
protocol
applic
submiss
fda
three
nine
member
ra
pharmacist
bring
uniqu
synopsi
emerg
prepared
respons
activ
three
pharmacist
regulatori
affair
program
ra
center
diseas
control
prevent
cdc
describ
ra
help
ensur
avail
use
medic
countermeasur
essenti
prepared
emerg
respons
program
cdc
ensur
regulatori
complianc
medic
countermeasur
potenti
threat
natur
chemic
biolog
radiolog
nuclear
event
ra
respond
pandem
influenza
outbreak
submit
multipl
emerg
use
author
eua
request
food
drug
administr
includ
medic
countermeasur
deploy
strateg
nation
stockpil
develop
cdc
eua
websit
analysi
pharmacist
interest
emerg
respons
prepared
activ
strengthen
nation
state
local
effort
prevent
respond
emerg
encourag
visit
http
emerg
cdcgov
interest
further
knowledg
regulatori
complianc
author
suggest
enrol
graduat
educ
program
focu
regulatori
affair
perspect
develop
protocol
provid
guidanc
drug
therapi
special
consider
advers
event
patient
monitor
cdc
task
hh
critic
oversight
ensur
avail
use
medic
countermeasur
cbrn
emerg
threat
ra
coordin
cdc
subject
matter
expert
support
task
initi
develop
protocol
execut
summari
fact
sheet
relat
support
document
requir
regulatori
mechan
ind
eua
ide
ra
serv
cdc
author
repres
submiss
fda
cdc
repres
hh
integr
product
team
meet
ie
smallpox
anthrax
botul
radiationnuclear
particip
hh
eua
work
group
meet
better
prepar
largescal
emerg
project
bioshield
act
includ
languag
section
feder
food
drug
cosmet
act
establish
eua
provis
titl
author
medic
product
use
emerg
provis
permit
fda
commission
upon
declar
emerg
secretari
hh
author
use
unapprov
product
unapprov
use
approv
product
diagnosi
treatment
prevent
seriou
lifethreaten
diseas
caus
cbrn
agent
adequ
approv
avail
altern
exist
follow
recent
exampl
ra
use
eua
mechan
respons
viru
april
ra
mobil
quickli
initi
draft
submit
multipl
eua
request
deploy
use
medic
countermeasur
includ
strateg
nation
stockpil
cdc
influenza
divis
consequ
ra
conven
subject
matter
expert
cdc
emerg
oper
center
initi
develop
five
eua
request
eua
request
requir
submiss
execut
summari
includ
justif
clinic
use
fact
sheet
health
care
provid
fact
sheet
patient
parentscaregiv
declar
public
health
emerg
involv
made
secretari
hh
april
span
hour
ra
submit
five
eua
request
author
fda
emerg
use
respir
variou
model
oseltamivir
capsul
oral
suspens
tamifluhoffmanla
roch
zanamivir
inhal
powder
relenzaglaxosmithklin
two
cdcdevelop
diagnost
devic
eua
issu
fda
commission
allow
initi
deploy
pro
rata
strateg
nation
stockpil
product
affect
state
order
augment
state
suppli
medic
countermeasur
allow
cdc
distribut
diagnost
devic
public
health
qualifi
laboratori
furthermor
fdaauthor
fact
sheet
provid
tangibl
educ
materi
health
care
provid
recipi
medic
countermeasur
use
eua
respir
fda
author
four
model
respir
use
gener
public
help
reduc
wearer
exposur
airborn
germ
public
health
medic
emerg
gener
public
broad
term
includ
peopl
perform
workrel
duti
respir
use
peopl
perform
workrel
duti
employ
must
compli
occup
safeti
health
administr
respiratori
protect
standard
cfr
see
wwwoshagov
inform
eua
oseltamivir
zanamivir
allow
approv
product
use
unapprov
indic
eua
allow
product
use
patient
symptomat
day
patient
complic
ill
requir
hospit
eua
oseltamivir
also
extend
product
use
includ
unapprov
popul
author
provid
dose
recommend
pediatr
patient
younger
year
age
addit
given
potenti
product
shortag
eua
allow
extend
use
certain
lot
oseltamivir
zanamivir
product
beyond
label
expiri
date
base
fda
review
support
stabil
potenc
data
addit
detail
regard
expir
product
avail
www
addit
develop
submiss
eua
request
ra
creat
cdc
eua
websit
wwwcdcgov
provid
essenti
inform
relat
fdaissu
eua
organ
euarel
materi
educ
outsid
audienc
stateloc
health
despeci
featur
pharmacist
regulatori
affair
cdc
partment
health
care
personnel
gener
public
eua
time
write
receiv
visit
still
view
daili
particular
interest
pharmacist
ra
monitor
need
implement
revis
oseltamivir
fact
sheet
health
care
provid
patient
parentscaregiv
potenti
dosag
administr
error
oseltamivir
oral
suspens
pediatr
addit
potenti
shortag
oseltamivir
suspens
exist
compound
instruct
also
consid
given
lack
gener
awar
understand
eua
public
health
emerg
declar
cdc
eua
websit
serv
educ
resourc
health
care
provid
gener
public
post
essenti
inform
regard
legal
regulatori
aspect
eua
specif
productrel
inform
answer
potenti
question
regard
acquisit
administr
product
ra
also
involv
develop
electron
system
health
care
provid
may
request
peramivir
eua
facilit
access
medic
countermeasur
hospit
around
nation
although
influenza
activ
caus
season
influenza
virus
may
rise
fall
incid
expect
persist
sever
month
occur
ra
respons
effort
public
health
emerg
would
continu
use
new
statesloc
health
depart
personnel
clinician
patient
affect
viru
may
receiv
medic
countermeasur
eua
turn
websit
euaspecif
materi
also
ra
continu
respons
pandem
request
addit
eua
medic
countermeasur
procur
distribut
cdc
pharmacist
learn
emerg
respons
prepared
activ
help
strengthen
nation
state
local
effort
prevent
respond
emerg
http
emergencycdcgov
addit
interest
further
knowledg
regulatori
complianc
seek
graduat
educ
program
focu
regulatori
affair
